Diagnostic contribution of EBUS in Interstitial Lung Desease (excluding Sarcoidosis)
W. Khamis (Bobigny, France), D. Basille (Amiens, France), J. Bernaudin (Bobigny, France), J. Morvan (Amiens, France), M. Soussan (Bobigny, France), M. Auquier (Amiens, France), K. Levand (Bobigny, France), P. Brillet (Bobigny, France), E. Magois (Amiens, France), C. Dayen (Saint-Quentin , France), Y. Douadi (Saint-Quentin , France), D. Valeyre (Bobigny, France), V. Jounieaux (Amiens, France), H. Nunes (Bobigny, France), O. Freynet (Bobigny, France)
Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF)
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
W. Khamis (Bobigny, France), D. Basille (Amiens, France), J. Bernaudin (Bobigny, France), J. Morvan (Amiens, France), M. Soussan (Bobigny, France), M. Auquier (Amiens, France), K. Levand (Bobigny, France), P. Brillet (Bobigny, France), E. Magois (Amiens, France), C. Dayen (Saint-Quentin , France), Y. Douadi (Saint-Quentin , France), D. Valeyre (Bobigny, France), V. Jounieaux (Amiens, France), H. Nunes (Bobigny, France), O. Freynet (Bobigny, France). Diagnostic contribution of EBUS in Interstitial Lung Desease (excluding Sarcoidosis). 2947
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: